Onychomycosis Treatment Market: Combination Treatment over Anti-fungal Drugs to Reduce Treatment Duration and to Boost Revenue Growth: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

  • Published: 2019-01-14
  • Report Code: REP-GB-1279

An Incisive, In-depth Analysis on the Onychomycosis Treatment Market

This study offers a comprehensive, 360 degree analysis on the Onychomycosis Treatment market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Onychomycosis Treatment market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

The Top Five Players Hold Around 43.9% of the Global Onychomycosis Treatment Market

The onychomycosis treatment market is a moderately consolidated market, with the top five leading players holding around 43.9% market share. These players include Valeant Pharmaceuticals Inc., Galderma S.A., Novartis AG, Pfizer, Inc., and Moberg Pharma AB. All these manufacturers have strong sales channels throughout the globe. Jublia, manufactured by Valeant Pharmaceuticals Inc., and Diflucan, manufactured by Pfizer, Inc., were the key brands generating major revenue in the onychomycosis treatment market in 2017. Revenue from Loceryl, by Galderma, and Lamisil, by Novartis, have shown 2x growth in the past three years. Valeant Pharmaceuticals Inc. has launched a Direct-to-Consumer (DTC) marketing campaign, which includes print, digital, and television to boost the sales of Jublia.

Increasing Elderly Population Around the Globe Has Fuelled the Growth of the Onychomycosis Treatment Market

According to WHO, age is the primary factor responsible for the development of onychomycosis, and the risk increases with age, particularly for persons aged >50 years. Approximately 80% to 85% of onychomycosis occurs in patients aged more than 50 years. Onychomycosis is reported to occur in 18.2% patients who are 60–79 years of age, compared to just 0.7% in patients younger than 19 years of age. Onychomycosis is common among the aged, with prevalence rates being as much as 20% in those aged 60 years, and 30% in those over 70 years of age. Thus, the increasing geriatric population is a major factor that is expected to drive growth of the onychomycosis treatment market during the forecast period.

Awareness Programmes by Non-profit Organizations to Fuel Sales of Onychomycosis Treatment Products

Awareness programs are organized by non-profit organizations to spread awareness among people about onychomycosis treatment. For instance, the British Association of Dermatologist has circulated leaflets among patients that include complete guidance for onychomycosis treatment. Similar awareness programmes are expected to raise the awareness levels among patients in both, developed and developing economies, which will fuel the growth of the onychomycosis treatment market over the forecast period.

Lack of Skilled Medical Professionals May Deter Growth of the Onychomycosis Treatment Market

Photodynamic therapy is the most advanced treatment option available for onychomycosis treatment. Skilled medical professionals are required to avoid any risk during the treatment period. But according to WHO, there will be a shortage of 12.9 million healthcare workers by 2035 across the globe. The demand for plastic surgeons has surged in the last few decades, whereas, the supply of plastic surgeons has declined. This demand-supply gap of plastic surgeons required to for photodynamic therapy for onychomycosis treatment may deter the growth of the onychomycosis treatment market.

Collaborations and Partnerships Are Key Strategies Being Followed by Leading Manufacturers in the Onychomycosis Treatment Market

There is an increasing trend of partnerships being witnessed among leading players in the onychomycosis treatment market. Companies are entering into marketing and sales agreements for their promotion of their products. For instance, in 2014, Anacor Pharmaceuticals Inc. entered into an exclusive agreement with Novartis AG for the sales and marketing of their products in the U.S. market. Also, in 2013, Moberg Pharma signed a distribution agreement with Leosons International LLC for the marketing of the Kerasal nail product in the Middle East and North Africa. This trend is being followed by a majority of manufacturers in the onychomycosis treatment market throughout the globe.

Competitive Landscape

The competition section of the onychomycosis treatment market report features the profiles of key players operating in the industry based on their market shares, differential strategies, product offerings, and marketing approach. Some of the key players featured in this report include Valeant PharmaceuticalsInc., Galderma S.A., Novartis AG, Pfizer, Inc., Moberg Pharma AB, Johnson & Johnson Services, Inc., Bayer AG, Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Medimetriks Pharmaceuticals, Inc., Lumenis Ltd., Biofrontera AG, and Leo Pharma A/S.Tier 1 players in the onychomycosis treatment market have a 37.3% market value share, and accounted for a market value of US$ 1.3 Bn in 2017.

Definition

Onychomycosis, also called tinea unguium, is a fungal infection of the nails. The symptoms of onychomycosis include white or yellow nail discoloration, thickening of the nails, and separation of the nails from the nail bed. Complications include cellulitis of the lower legs. Onychomycosis is caused by a number of fungi such as dermatophytes, Candida (yeast), and nondermatophytic molds.

About the Report

FMI conducted a research study on the onychomycosis treatment market for the forecast period 2018 to 2028. The report offers a comprehensive evaluation of the business opportunities prevailing in the onychomycosis treatment market, along with insights on the prevalence and treatment seeking rates in top countries, onychomycosis treatment options by region, and key regulatory and reimbursement scenarios. The report also elaborates on the macroeconomic factors influencing the dynamics of the onychomycosis treatment market and its futuristic potential.

Segmentation

The report offers a comprehensive taxonomy of the onychomycosis treatment market based on treatment type, indication, gender, age group, end user, and region. Different treatment options are available for onychomycosis treatment, which include drugs, lasers, and photodynamic therapy. All this options are taken into consideration while estimating and forecasting the market value for onychomycosis treatment. Indications such as distal subungual onychomycosis, white superficial onychomycosis, proximal subungual onychomycosis, candidal onychomycosis, and total dystrophic onychomycosisare included in indication segment of the report. The global onychomycosis treatment market report also includes the end user segment, which covers institutional sales and retail sales. The onychomycosis treatment market has been analyzed across the regions of North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan, and MEA.

Additional Questions Answered

Some of the additional questions addressed in this report on the onychomycosis treatment market-

  • What is the revenue potential of photodynamic therapy across the regions of North America and Europe?

  • Who are the key competitors in the onychomycosis treatment market, and what are their product portfolios and growth hacking strategies?

  • What are major factors influencing the growth of the onychomycosis treatment market?

  • Which are the trend followed by the leading manufacturer to retain their market share?

  • What is the prevalence and treatment seeking rates for onychomycosis treatment in the top countries?

Research Methodology

The onychomycosis treatment market has been estimated based on a supply-demand approach. Firstly, the prevalence and treatment seeking rates of onychomycosis are estimated for the top 20 countries to estimate the patient pool adopting onychomycosis treatment. After that, the costs of different onychomycosis treatment options are analyzed to estimate the market value for onychomycosis treatment. This information is further validated with rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases). The research study on the onychomycosis treatment market also includes the top trends and macro as well as micro economic factors shaping the market. With this approach, the report on the onychomycosis treatment market anticipates the industry attractiveness of every major segment over the forecast period.

A recent market study published by FMI – 'Onychomycosis Treatment Market: Global Industry Analysis 2013-2017 & Opportunity Assessment 2018-2028', consists of a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the onychomycosis treatment market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may have a huge impact on the development of the onychomycosis treatment market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the onychomycosis treatment market in the coming years. The report provides detailed information about the current and future growth prospects of the onychomycosis treatment market in the most comprehensive way for the better understanding of the readers.

Chapter 1 – Executive Summary

The report commences with the executive summary of the onychomycosis treatment market, which includes the summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments in the onychomycosis treatment market.

Chapter 2 – Market Introduction

Readers can find a detailed taxonomy and the definition of the onychomycosis treatment market in this chapter, which helps them understand the basic information about onychomycosis treatment. This section also highlights the inclusions and exclusions, which helps readers understand the scope of the report.

Chapter 3 – Market Opportunity Analysis

This chapter explains the key macro-economic factors that are influencing the growth of the onychomycosis treatment market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the onychomycosis treatment market. This chapter helps readers understand the market opportunity that provides them leverage to plan their strategy accordingly.

Chapter 4 – Market Background

This chapter highlights the key market dynamics, including the drivers, restraints, and trends. Both, supply-side drivers and demand-side drivers of the onychomycosis treatment market are explained well in this chapter. Readers can understand the factors that are propelling the growth of the onychomycosis treatment market, along with factors that may deter the growth of the market. Readers will also understand the key trends followed by leading manufacturers in the onychomycosis treatment market.

Chapter 5 – Key Inclusions

This chapter highlights key inclusions of the report such as key regulations, reimbursement scenario, and pipeline assessment. Parent market analysis helps readers understand the share of the global onychomycosis treatment market in the overall dermatology market. The key regulations section of this chapter highlights the FDA and EMA regulatory process for the approval of drugs. The reimbursement scenario provides CPT codes used for onychomycosis treatment. Also, the detailed explanation about each CPT code is mentioned in this section. The pipeline assessment includes a list of clinical trials going on for onychomycosis treatment around the world.

Chapter 6 – Global Economic Outlook

This section highlights the expenditure on health by the top countries in each region. It also explains the global and regional healthcare market outlook. The regional healthcare market focuses to explain deeply about the political, economic and business environment outlook of the respective region.

Chapter 7 – North America Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth of the North America onychomycosis treatment market, along with a country-wise assessment, including the U.S. and Canada. Readers can also find the key takeaways of this region, and market growth based on treatment type, indication, gender, age group, end user, and country of the onychomycosis treatment market in the North American region.

Chapter 8 – Latin America Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

Readers can find a snapshot of the Latin America onychomycosis treatment market in this chapter. This chapter includes the growth prospects of the onychomycosis treatment market in leading LATAM countries such as Brazil, Mexico, and the rest of the Latin American region.

Chapter 9 – Western Europe Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

Important growth prospects of the onychomycosis treatment market based on its treatment type, indication, gender, age group, and end user in several European countries such as the U.K., Germany, France, Italy, Spain, and the rest of the Western Europe are included in this chapter.

Chapter 10 – Eastern Europe Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This chapter highlights the market growth of the onychomycosis treatment market in Eastern Europe by focusing on Russia and Poland. This section also helps readers understand the key factors that are responsible for the growth of the onychomycosis treatment market in Eastern Europe.

Chapter 11 – APECJ Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

Australia and New Zealand, India, China, and ASEAN are the leading countries/regions in the APECJ region that are the prime subject of assessment to obtain the growth prospects of the APECJ onychomycosis treatment market, in this chapter. Readers can find thorough information about the growth parameters of the APEJ onychomycosis treatment market during the period 2018-2028.

Chapter 12 – Japan Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

Readers can find important factors that can have a huge impact on the growth of the onychomycosis treatment market in Japan, based on the market segmentation, during the forecast period. This chapter highlights the key factors that are impacting the growth of the Japan onychomycosis treatment market over the forecast period.

Chapter 13 – MEA Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This chapter provides information on how the onychomycosis treatment market will grow in major countries in MEA region, such as GCC Countries and South Africa, during the period 2018-2028.

Chapter 14 – Forecast Factors – Relevance and Impact

This chapter highlights the key factors taken into consideration while forecasting market value for the global onychomycosis treatment market. The impact of these forecast factors in different regions is also mentioned in this chapter.

Chapter 15 – Forecast Assumptions

This section helps readers understand the assumptions taken into account while estimating and forecasting the market size of onychomycosis treatment. The relative weightage of these assumptions are also mentioned in this section.

Chapter 16 – Market Structure Analysis

This section explains the tier structure of the global onychomycosis treatment market, which helps readers understand the percent share of market cover by tier 1, tier 2, and tier 3 players in this market. This section also explains company share analysis for the onychomycosis treatment market, which helps readers understand the market share taken by key players in the market.

Chapter 17 – Competition Landscape

In this chapter, readers can find a comprehensive list of all the leading manufacturers in the onychomycosis treatment market, along with detailed information about each company, including company overview, revenue share, strategic overview, recent company developments, and SWOT analysis. Market players featured in the report include Valeant Pharmaceuticals Inc., Galderma S.A., Novartis AG, Pfizer, Inc., Moberg Pharma AB, Johnson & Johnson Services, Inc., Bayer AG, Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Medimetriks Pharmaceuticals, Inc., Lumenis Ltd., Biofrontera AG, and Leo Pharma A/S.

Chapter 18 – Global Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 by Region

This chapter explains how the onychomycosis treatment market will grow across various geographic regions such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA).

Chapter 19 – Global Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 by Treatment Type

Based on treatment type, the onychomycosis treatment market is segmented into drugs, lasers, and photodynamic therapy. In this chapter, readers can find detailed analysis of the market by different treatment types and their growth over the forecast period.

Chapter 20 – Global Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 by Indication

Based on Indication, the onychomycosis treatment market is segmented into distal subungual onychomycosis, white superficial onychomycosis, proximal subungual onychomycosis, candidal onychomycosis, and total dystrophic onychomycosis. This section helps readers understand the different indications in the market over the forecast period.

Chapter 21 – Global Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 by Gender

Based on gender, the onychomycosis treatment market is segmented into male and female. This section helps readers analyze the prevalence of onychomycosis among both genders.

Chapter 22 – Global Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 by Age Group

Based on age group, the onychomycosis treatment market is segmented into 0-18 years, 18-39 years, 40-64 years, and 65 years and above. This section helps readers analyze the penetration of onychomycosis treatment among different age groups.

Chapter 23 – Global Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 by End User

Based on end user, the onychomycosis treatment market is segmented intoinstitutional sales and retail sales. In this chapter, readers can find information on market attractiveness analysis based on end users.

Chapter 24 – Global Onychomycosis Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This section explain the global market analysis and forecast for the onychomycosis treatment market. It also highlights the incremental opportunity for the onychomycosis market, along with absolute dollar opportunity for every year between the forecast period 2018-2028.

Chapter 25 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 26 – Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the onychomycosis treatment market.

Onychomycosis Treatment Market Reports - Table of Contents

Onychomycosis Treatment Market Reports - List of Tables

  1. Product Pipeline Analysis for Onychomycosis

  2. Reimbursement Analysis for Onychomycosis

  3. Expenditure on Health, (% of GDP), by Country, 2016 - 2021

  4. Expenditure on Health, (% of GDP), by Country, 2016 - 2021

  5. North America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

  6. North America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment

  7. North America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication

  8. North America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender

  9. North America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group

  10. North America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  11. Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

  12. Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment

  13. Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication

  14. Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender

  15. Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group

  16. Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  17. Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

  18. Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment

  19. Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication

  20. Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender

  21. Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group

  22. Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  23. Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

  24. Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment

  25. Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication

  26. Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender

  27. Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group

  28. Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  29. Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

  30. Asia Pacific Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment

  31. Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication

  32. Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender

  33. Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group

  34. Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  35. China Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment

  36. China Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication

  37. China Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender

  38. China Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group

  39. China Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  40. Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment

  41. Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication

  42. Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender

  43. Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group

  44. Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  45. MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

  46. Middle East and Africa Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Treatment

  47. MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication

  48. MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Gender

  49. MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Age Group

  50. MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  51. Onychomycosis Treatment Market Value (US$ Mn) 2013–2017 and Forecast 2018-2026 By Region

  52. Global Onychomycosis Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment

  53. Onychomycosis Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication

  54. Onychomycosis Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Gender

  55. Global Onychomycosis Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Age Group

  56. Middle East & Africa Onychomycosis Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User

Onychomycosis Treatment Market Reports - List of Figures

  1. Global Onychomycosis Treatment Market Value Share By Treatment (2018 E)

  2. Global Onychomycosis Treatment Market Value Share By Indication (2018 E)

  3. Global Onychomycosis Treatment Market Value Share By Gender(2018 E)

  4. Global Onychomycosis Treatment Market Value Share By Age Group (2018 E)

  5. Global Onychomycosis Treatment Market Value Share By End User(2018 E)

  6. Global Onychomycosis Treatment Market Value Share By Region (2018 E)

  7. GDP (US$ Trillion) and Healthcare Expenditure % (2017)

  8. Net National income, Income Growth and Employment (2014)

  9. Onychomycosis Incidence by Income Group (2017)

  10. Onychomycosis Rate by Age Group (2017)

  11. Pipeline Analysis for Onychomycosis, By Phase

  12. Number of Clinical Trials for Onychomycosis, By Study Type

  13. Global Healthcare Expenditure in US$ Tn (2013–2020)

  14. North America Onychomycosis Treatment Market Share, By Country (2018E)

  15. North America Onychomycosis Treatment Market Share, By Treatment (2018E)

  16. North America Onychomycosis Treatment Market Share, By Indication (2018E)

  17. North America Onychomycosis Treatment Market Share, By Gender (2018E)

  18. North America Onychomycosis Treatment Market Share, By Age Group (2018E)

  19. North America Onychomycosis Treatment Market Share, By End Users (2018E)

  20. North America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  21. North America Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  22. U.S. Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  23. U.S. Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  24. Canada Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  25. Canada Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  26. North America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs

  27. North America Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs

  28. North America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers

  29. North America Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers

  30. North America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  31. North America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  32. North America Onychomycosis Treatment Market Attractiveness Analysis, By Country , 2018-2028

  33. North America Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028

  34. North America Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028

  35. North America Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028

  36. North America Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028

  37. North America Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028

  38. Latin America Onychomycosis Treatment Market Share, By Country (2018E)

  39. Latin America Onychomycosis Treatment Market Share, By Treatment (2018E)

  40. Latin America Onychomycosis Treatment Market Share, By Indication (2018E)

  41. Latin America Onychomycosis Treatment Market Share, By Gender (2018E)

  42. Latin America Onychomycosis Treatment Market Share, By Age Group (2018E)

  43. Latin America Onychomycosis Treatment Market Share, By End Users (2018E)

  44. Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  45. Latin America Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  46. Brazil Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  47. Brazil Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  48. Mexico Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  49. Mexico Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  50. Argentina Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  51. Argentina Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  52. Rest of Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  53. Rest of Latin America Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  54. Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs

  55. Latin America Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs

  56. Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers

  57. Latin America Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers

  58. Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  59. Latin America Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  60. Latin America Onychomycosis Treatment Market Attractiveness Analysis, By Country , 2018-2028

  61. Latin America Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028

  62. Latin America Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028

  63. Latin America Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028

  64. Latin America Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028

  65. Latin America Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028

  66. Western Europe Onychomycosis Treatment Market Share, By Country (2018E)

  67. Western Europe Onychomycosis Treatment Market Share, By Treatment (2018E)

  68. Western Europe Onychomycosis Treatment Market Share, By Indication (2018E)

  69. Western Europe Onychomycosis Treatment Market Share, By Gender (2018E)

  70. Western Europe Onychomycosis Treatment Market Share, By Age Group (2018E)

  71. Western Europe Onychomycosis Treatment Market Share, By End Users (2018E)

  72. Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  73. Western Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  74. Germany Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  75. Germany Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  76. France Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  77. France Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  78. Italy Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  79. Italy Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  80. Spain Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  81. Spain Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  82. U.K. Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  83. U.K Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  84. Benelux Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  85. Benelux Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  86. Nordics Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  87. Nordics Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  88. Rest of Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  89. Rest of Western Europe Onychomycosis Treatment Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  90. Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs

  91. Western Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs

  92. Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers

  93. Western Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers

  94. Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  95. Western Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  96. Western Europe Onychomycosis Treatment Market Attractiveness Analysis, By Country , 2018-2028

  97. Western Europe Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028

  98. Western Europe Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028

  99. Western Europe Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028

  100. Western Europe Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028

  101. Western Europe Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028

  102. Eastern Europe Onychomycosis Treatment Market Share, By Country (2018E)

  103. Eastern Europe Onychomycosis Treatment Market Share, By Treatment (2018E)

  104. Eastern Europe Onychomycosis Treatment Market Share, By Indication (2018E)

  105. Eastern Europe Onychomycosis Treatment Market Share, By Gender (2018E)

  106. Eastern Europe Onychomycosis Treatment Market Share, By Age Group (2018E)

  107. Eastern Europe Onychomycosis Treatment Market Share, By End Users (2018E)

  108. Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  109. Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  110. Russia Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  111. Russia Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  112. Poland Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  113. Poland Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  114. Rest of Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  115. Rest of Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  116. Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs

  117. Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs

  118. Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers

  119. Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers

  120. Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  121. Eastern Europe Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  122. Eastern Europe Onychomycosis Treatment Market Attractiveness Analysis, By Country , 2018-2028

  123. Eastern Europe Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028

  124. Eastern Europe Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028

  125. Eastern Europe Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028

  126. Eastern Europe Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028

  127. Eastern Europe Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028

  128. Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Share, By Country (2018E)

  129. Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Share, By Treatment (2018E)

  130. Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Share, By Indication (2018E)

  131. Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Share, By Gender (2018E)

  132. Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Share, By Age Group (2018E)

  133. Asia Pacific Excluding China & Japan Onychomycosis Treatment Market Share, By End Users (2018E)

  134. APECJ Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  135. APECJ Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  136. India Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  137. India Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  138. ASEAN Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  139. ASEAN Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  140. Australia & New Zealand Treatment Market Value (US$ Mn) Analysis, 2013–2017

  141. Australia & New Zealand Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  142. Rest of APECJ Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  143. Rest of APECJ Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  144. APECJ Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs

  145. APECJ Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs

  146. APECJ pan Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers

  147. APECJ n Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers

  148. APECJ Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  149. APECJ Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  150. APECJ Onychomycosis Treatment Market Attractiveness Analysis, By Country , 2018-2028

  151. APECJ Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028

  152. APECJ Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028

  153. APECJ Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028

  154. APECJ Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028

  155. APECJ Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028

  156. China Onychomycosis Treatment Market Share, By Gender (2018E)

  157. China Onychomycosis Treatment Market Share, By Treatment (2018E)

  158. China Onychomycosis Treatment Market Share, By Indication (2018E)

  159. China Onychomycosis Treatment Market Share, By Age Group (2018E)

  160. China Onychomycosis Treatment Market Share, By End Users (2018E)

  161. China Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  162. China Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  163. China Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs

  164. China Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs

  165. China Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers

  166. China Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers

  167. China Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  168. China Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  169. China Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028

  170. China Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028

  171. China Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028

  172. China Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028

  173. China Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028

  174. Japan Onychomycosis Treatment Market Share, By Gender (2018E)

  175. Japan Onychomycosis Treatment Market Share, By Treatment (2018E)

  176. Japan Onychomycosis Treatment Market Share, By Indication (2018E)

  177. Japan Onychomycosis Treatment Market Share, By Age Group (2018E)

  178. Japan Onychomycosis Treatment Market Share, By End Users (2018E)

  179. Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  180. Japan Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  181. Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs

  182. Japan Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs

  183. Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers

  184. Japan Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers

  185. Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  186. Japan Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  187. Japan Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028

  188. Japan Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028

  189. Japan Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028

  190. Japan Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028

  191. Japan Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028

  192. MEA Onychomycosis Treatment Market Share, By Country (2018E)

  193. MEA Onychomycosis Treatment Market Share, By Treatment (2018E)

  194. MEA Onychomycosis Treatment Market Share, By Indication (2018E)

  195. MEA Onychomycosis Treatment Market Share, By Gender (2018E)

  196. MEA Onychomycosis Treatment Market Share, By Age Group (2018E)

  197. MEA Onychomycosis Treatment Market Share, By End Users (2018E)

  198. MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  199. MEA Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  200. GCC Countries Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  201. GCC Countries Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  202. South Africa Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  203. South Africa Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  204. Rest of MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017

  205. Rest of MEA Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  206. MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Drugs

  207. MEA Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Drugs

  208. MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Lasers

  209. MEA Onychomycosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Lasers

  210. MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  211. MEA Onychomycosis Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Photodynamic Therapy

  212. MEA Onychomycosis Treatment Market Attractiveness Analysis, By Country, 2018-2028

  213. MEA Onychomycosis Treatment Market Attractiveness Analysis, By Treatment, 2018-2028

  214. MEA Onychomycosis Treatment Market Attractiveness Analysis, By Indication, 2018-2028

  215. MEA Onychomycosis Treatment Market Attractiveness Analysis, By Gender, 2018-2028

  216. MEA Onychomycosis Treatment Market Attractiveness Analysis, By Age Group, 2018-2028

  217. MEA Onychomycosis Treatment Market Attractiveness Analysis, By End User, 2018-2028

  218. Global Onychomycosis Treatment Market 2017, Parent Market

  219. Dermatophytic Onychomycosis Therapeutics Market: Company Share Analysis (2017)

  220. Global Onychomycosis Treatment Market Share Analysis (%) By Region, 2018 & 2028

  221. Global Onychomycosis Treatment Market Y-o-Y Growth (%) By Region, 2017–2028

  222. Global Onychomycosis Treatment Market Attractiveness Analysis By Region, 2018–2028

  223. Global Onychomycosis Treatment Market Share Analysis (%) By Treatment, 2018 & 2028

  224. Global Onychomycosis Treatment Market Y-o-Y Growth (%) By Treatment, 2017–2028

  225. Global Onychomycosis Treatment Market Attractiveness Analysis By Treatment, 2018–2028

  226. Global Onychomycosis Treatment Market Share Analysis (%) By Indication, 2018 & 2028

  227. Onychomycosis Treatment Market Y-o-Y Growth (%) By Indication, 2017–2028

  228. Global Onychomycosis Treatment Market Attractiveness Analysis By Indication, 2018–2028

  229. Global Onychomycosis Treatment Market Share Analysis (%) By Gender, 2018 & 2028

  230. Onychomycosis Treatment Market Y-o-Y Growth (%) By Gender, 2017–2028

  231. Global Onychomycosis Treatment Market Attractiveness Analysis By Gender, 2018–2028

  232. Global Onychomycosis Treatment Market Share Analysis (%) By Age Group, 2018 & 2028

  233. Global Onychomycosis Treatment Market Y-o-Y Growth (%) By Age Group, 2017–2028

  234. Global Onychomycosis Treatment Market Attractiveness Analysis By Age Group, 2018–2028

  235. Global Onychomycosis Treatment Market Share Analysis (%) By End User, 2018 & 2028

  236. Onychomycosis Treatment Market Y-o-Y Growth (%) By End User, 2017–2028

  237. Global Onychomycosis Treatment Market Attractiveness Analysis By End User, 2018–2028

  238. Global Onychomycosis Treatment Market Value Analysis and Forecast, 2017–2026 (US$ Mn)

  239. Global Onychomycosis Treatment Market Absolute $ Opportunity, 2013–2028

Get in touch

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology